Login / Signup

Clinical Outcomes of Older and Younger Patients Treated with Loncastuximab Tesirine in the LOTIS-2 Clinical Trial.

Mehdi HamadaniAlexander I SpiraXiaolei ZhouLaura LiaoLei ChenJohn RadfordWeiyun Z AiMelhem M SolhKirit M ArdeshnaBrian T HessPaolo F CaimiAnastasios StathisCarmelo Carlo StellaJuan Pablo AlderuccioBrad S KahlYing WangYajuan Gu QinZhiying Cindy XuPier Luigi Luigi Zinzani
Published in: Blood advances (2023)
Keyphrases
  • clinical trial
  • community dwelling
  • middle aged
  • phase ii
  • physical activity
  • open label
  • double blind
  • study protocol
  • phase iii
  • randomized controlled trial